MONOCLONAL ANTIBODY THERAPEUTICS MARKET ANALYSIS

Regional Analysis

Global Monoclonal Antibody Therapeutics Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global monoclonal antibody therapeutics market over the forecast period. North America holds 45.1% of the market share due to the increasing prevalence of autoimmune diseases in the region. According to the data published by the National Institute of Health, in April 2020, 41 million people were diagnosed with autoimmune diseases from past 10 years.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa